We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Quidel (QDEL) Stock Moves -0.87%: What You Should Know
Read MoreHide Full Article
Quidel (QDEL - Free Report) closed at $224.21 in the latest trading session, marking a -0.87% move from the prior day. This change was narrower than the S&P 500's 2.57% loss on the day. At the same time, the Dow lost 2.05%, and the tech-heavy Nasdaq lost 2.61%.
Wall Street will be looking for positivity from QDEL as it approaches its next earnings report date. In that report, analysts expect QDEL to post earnings of $10.10 per share. This would mark year-over-year growth of 910%. Our most recent consensus estimate is calling for quarterly revenue of $807.91 million, up 430.89% from the year-ago period.
Investors might also notice recent changes to analyst estimates for QDEL. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 7.41% lower within the past month. QDEL is currently a Zacks Rank #3 (Hold).
Digging into valuation, QDEL currently has a Forward P/E ratio of 6.08. Its industry sports an average Forward P/E of 29.25, so we one might conclude that QDEL is trading at a discount comparatively.
Meanwhile, QDEL's PEG ratio is currently 0.24. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. QDEL's industry had an average PEG ratio of 3.07 as of yesterday's close.
The Medical - Products industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 216, which puts it in the bottom 16% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow QDEL in the coming trading sessions, be sure to utilize Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Quidel (QDEL) Stock Moves -0.87%: What You Should Know
Quidel (QDEL - Free Report) closed at $224.21 in the latest trading session, marking a -0.87% move from the prior day. This change was narrower than the S&P 500's 2.57% loss on the day. At the same time, the Dow lost 2.05%, and the tech-heavy Nasdaq lost 2.61%.
Wall Street will be looking for positivity from QDEL as it approaches its next earnings report date. In that report, analysts expect QDEL to post earnings of $10.10 per share. This would mark year-over-year growth of 910%. Our most recent consensus estimate is calling for quarterly revenue of $807.91 million, up 430.89% from the year-ago period.
Investors might also notice recent changes to analyst estimates for QDEL. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 7.41% lower within the past month. QDEL is currently a Zacks Rank #3 (Hold).
Digging into valuation, QDEL currently has a Forward P/E ratio of 6.08. Its industry sports an average Forward P/E of 29.25, so we one might conclude that QDEL is trading at a discount comparatively.
Meanwhile, QDEL's PEG ratio is currently 0.24. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. QDEL's industry had an average PEG ratio of 3.07 as of yesterday's close.
The Medical - Products industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 216, which puts it in the bottom 16% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow QDEL in the coming trading sessions, be sure to utilize Zacks.com.